Skip to content

Effects of combined therapy of upper body elebation and highflow nasal cannula on postoperative high-sensitivity troponin T in severe obstructive sleep apnea patients undergoing major surgery: a randomized control study

Effects of combined therapy of upper body elebation and highflow nasal cannula on postoperative high-sensitivity troponin T in severe obstructive sleep apnea patients undergoing major surgery: a randomized control study - high flow nasal cannula and postoperative troponin T

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000048103
Enrollment
40
Registered
2022-06-20
Start date
2022-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial injury after noncardiac surgery

Interventions

a combination of upper body elebation and high flow nasal cannula a combination of supine and oxygen therapy

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients undergoing major thoracic or abdominal surgery under general anesthesia combined with thoracic epidural anesthesia who have at least more than 3 risk factors for Myocardial Injury after Non-cardiac Surgery such as older than 75 years, male, atrial fibrillation, diabetes, hypertension, cardiac failure (history), coronary artery disease, peripheral vascular disease, renal dysfunction (eGFR<60), and stroke.

Exclusion criteria

Exclusion criteria: 1. emergency surgery 2. palliative operation 3. severe renal dysfunction (eGFR<15 or dialysis patients) 4. severe respiratory disease with hypoxemia and/or hypercapnia 5. oxygen therapy before surgery 6. unable to accept high-flow nasal cannula therapy 7. renal and ureteral surgery 8. sepsis 9. use of antimicrobials before surgery 10. pulmonary embolism 11. preoperative high-sensitivity troponin T levels greater than or equal to0.065 ng/mL 12. difficulty of obtaining concents from the patient 13. judged by the principal investigator to be inappropriate as a participant

Design outcomes

Primary

MeasureTime frame
maximum difference of high-sensitivity troponin T before and after surgery

Secondary

MeasureTime frame
incidence of Myocardial Injury after Non-cardiac Surgery, incidence of high-sensitivity troponin T greater than 0.005 ng/mL, major postoperative complications within 30 days after surgery,

Countries

Japan

Contacts

Public ContactYoshihiro Yamaji

Graduate School of Medicine, Chiba University Department of Anesthesiology

yamayoshi1228@yahoo.co.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026